Granules Pharmaceuticals Inc. is a US-based subsidiary of Granules India, specializing in the development and manufacturing of high-quality, affordable oral solid dosage pharmaceuticals from its FDA and DEA-approved facility in Chantilly, Virginia.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Granules Pharmaceuticals Inc. has recently focused on expanding its manufacturing capabilities, launching new generic products, and enhancing its regulatory compliance to meet growing US market demand.
Expansion of manufacturing lines and facility upgrades in Chantilly, Virginia
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Granules Pharmaceuticals Inc. manufactures and distributes a diverse portfolio of oral solid dosage pharmaceuticals, including immediate, modified, and extended-release tablets and capsules, as well as powders for oral solutions. The company’s Chantilly, Virginia facility is equipped for complex, low-volume manufacturing and also supports R&D activities. Granules Pharmaceuticals distributes products under its own GPI label and through integrated supply chains with its parent company in India. The company is committed to quality, compliance, and providing affordable alternatives to brand-name medications.
Chantilly, Virginia
2016
Private company
